(Q34689078)
Statements
1 reference
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells (English)
1 reference
Elena Saba
1 reference
Alessandro M Gianni
1 reference
19 April 2013
1 reference
19 April 2013
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference